Israeli cannabis start-up launches exciting new product

Medical cannabis company, Medican Pharma, recently launched Allegro, a new product from the SEVEN cannabis brand series. This is medical cannabis grown under controlled and optimal conditions.

"Adhering to existing regulations regarding the growing conditions of cannabis will help reduce cases of mold and fungus, yet only up to a certain level," emphasizes Assaf Sela, CEO of the medical cannabis manufacturing company Medican Pharma.

The Medican Group led by brothers Assaf and Tal Sela is the fourth generation to work in agriculture and innovation. The brothers entered the field of medical cannabis when their grandmother was diagnosed with dementia and began treatment with medical cannabis.

Over the years of treatment and after seeing its transformative effects, the family began to research, study and explore methods to ensure the complete maintenance of safety, uniformity and quality to allow adherence to a therapeutic sequence of medical cannabis products for patients.

Sela explains that overcrowding of plants, fluctuations in the weather, improper growingth conditions, non-compliance with the sanitation requirements of planting spaces along with lack of care for the drying and aging processes and more can lead to the development of undesirable conditions that cause molds, fungi, and consequently poor quality medical cannabis.

The company recently launched a new product, Allegro, from the cannabis brand series SEVEN. This is an ultra-premium level medical cannabis, grown under controlled and optimal conditions. The cultivation was done at a facility that the company established in the central area for the growth and harvesting of medical cannabis.

This facility is a unique combination of high-tech, agro-tech and pharma-tech. It’s a clean, closed and completely controlled environment which allows for optimal care for product safety, without using pesticides, and which is able to maintain the concentration of active ingredients of the plants at the maximum levels and evenly throughout the various growth cycles.

The company distributes its products through Madison Pharma and participates in clinical trials.

https://www.jpost.com/business-and-innovation/article-709155